Professor Sarah-Jane Dawson provides an update on the CAPTURE clinical trial скачать в хорошем качестве

Professor Sarah-Jane Dawson provides an update on the CAPTURE clinical trial

Professor Sarah-Jane Dawson is the study chair of the CAPTURE clinical trial. She provides an update for supporters on the CAPTURE clinical trial. CAPTURE is an Australian clinical trial which will enrol 140 patients. It is open to both women and men diagnosed with Oestrogen-receptor (ER) positive and Human Epidermal Growth Factor Receptor 2 (HER-2) negative breast cancer that has returned after treatment with a CDK4/6 inhibitor (such as ribociclib, palbociclib, abemaciclib). The CAPTURE clinical trial will investigate if treatment with a PI3K inhibitor (alpelisib), in combination with fulvestrant, will improve outcomes for patients with metastatic breast cancer when compared with standard treatment. ---------------------------------------------------------------- Breast Cancer Trials is a group of world-leading breast cancer doctors and researchers based in Australia and New Zealand committed to exploring and finding better treatments for people affected by breast cancer through clinical trials research. Please like this video then visit www.breastcancertrials.org.au to find out more about our current breast cancer clinical trials that may be suitable for you, and ways in which you can help support breast cancer research. ---------------------------------------------------------------- SUBSCRIBE TO OUR YOUTUBE CHANNEL    / @breastcancertrials   LET'S CONNECT Email ►[email protected] Tel 1800 423 444 WWW ► http://www.breastcancertrials.org.au Linkedin ►   / 5057154   Twitter ►   / bctrialsanz   Facebook ►   / breastcancertrials   Instagram ►   / breastcancertrials